{
  "pmcid": "8142440",
  "sha256": "370bcd29445c87e4632527de36f2fca52a5d552bf673cf7777e27f77084a3e51",
  "timestamp_utc": "2025-11-09T16:16:59.753704+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 11.635094111969114,
    "reading_ease": 40.4765021718147,
    "word_count": 259
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "140 carotid artery stenting procedures, including 40% of patients at high risk and 60% at normal risk for CEA, were performed in 13 institutes."
      },
      "Participants": {
        "score": 2,
        "evidence": "Eligible patients had ≥50% symptomatic stenosis or ≥80% asymptomatic stenosis according to the North American Symptomatic Carotid Endarterectomy Trial methods"
      },
      "Intervention": {
        "score": 2,
        "evidence": "The dual-layer nitinol CASPER stent was designed to prevent plaque prolapse into its strut and periprocedural stroke."
      },
      "Objective": {
        "score": 1,
        "evidence": "Objective: To conduct a clinical trial for government approval of the device in patients at either high or normal risk for carotid endarterectomy (CEA)."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary endpoint was the lack of major adverse events (MAEs), defined as death, stroke, and myocardial infarction within 30 days, and ipsilateral stroke within 1 year."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "140 carotid artery stenting procedures, including 40% of patients at high risk and 60% at normal risk for CEA, were performed in 13 institutes."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "MAEs occurred in two cases (one intraprocedural and one postprocedural stroke), and the MAE rate was 1.4%. The non-MAE rate was 98.6% according to Kaplan-Meier analysis, which was superior to the previously set performance goal."
      },
      "Harms": {
        "score": 1,
        "evidence": "MAEs occurred in two cases (one intraprocedural and one postprocedural stroke)"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 13,
    "max_score": 25
  }
}